newsfilter
← Interviews
The Economist7 min

Why pig organ transplants are closer than ever

Emilie Steinmark, Alok Jha, Emily

Interview

Faced with a global organ shortage where 90% of candidates die waiting, the medical field has pivoted to genetically engineered pig organs as the primary solution due to their physiological compatibility and scalable breeding. Scientists achieve this by removing pig-specific antigens and inserting human genes to regulate immune responses and functions like blood clotting, creating sterile, custom-fitted organs within a seven-month growth cycle. While initially reserved for specific high-need patients, these bio-engineered transplants aim to eventually surpass the variable quality of human donors and expand access to life-saving treatments.